Defining immune-evasive mechanical signaling in head and neck cancer
Project Number1R01DE033519-01
Contact PI/Project LeaderVARELAS, XARALABOS Other PIs
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
Project Summary
Head and neck cancer squamous cell carcinomas (HNSCC) are the seventh most common cancers globally
and are associated with poor survival rates. Pharmacological treatments for HNSCC remain largely ineffective
and improving therapies requires the identification of novel factors that modulate not just the tumor but also the
surrounding permissive oral microenvironment. Aging is a variable tightly associated with HNSCC development
and is linked to tissue alterations and defective immune responses. However, while older chronological age is
associated with tumor development and elderly HNSCC patients exhibit worse five-year survival, very little is
known about the molecular mechanisms by which aging contributes to the etiology of HNSCC. The goal of this
proposal is to define signals associated with HNSCC progression in aged tissues with the hope to uncover
targetable mechanisms that may offer new therapeutic avenues. To test the influence of age on HNSCC, we
optimized syngeneic orthotopic tongue xenograft models of HNSCC and have observed more rapid tumor
growth in old animals, with tumors exhibiting an age-associated, immune evasive and transcriptionally-distinct
tumor cell states. We have found that these age-associated alterations correlate with increased extracellular
matrix levels that we hypothesize the mechanical properties of old tissues direct distinct mechanosensitive
signals. Our observations suggest that the mechanical-effector YAP, a transcriptional regulator mediating
Hippo pathway signaling that has pro-tumorigenic functions in HNSCC, is linked to age-associated
tumorigenesis. We propose to examine the relationship between aging, extracellular matrix dynamics, YAP
activity and YAP-directed functions, including immune evasion. We further plan to compare matrix dynamics
and tissue elasticity across mice of different chronological age and test how increasing collagen levels or
reducing collagen crosslinking affects tumorigenic behavior. We will further test the consequences of inhibiting
YAP activity in age-associated tumors, profiling accompanying transcriptional and cellular changes. Finally, we
will test how reintroducing an absent chemokine program regulated by YAP that is repressed in the old tongue
microenvironment impacts tumor growth and tumor lymphocyte infiltration. Data collected from our study will
provide a comprehensive assessment of age-associated mechanical signals and offer new insight into
mechanisms that may direct the heterogenous lymphocytic functions observed in HNSCC.
Public Health Relevance Statement
Project Narrative
Head and neck cancers rank among the deadliest and most diagnosed cancers globally. Treatment strategies
for head and neck cancers are limited, with emerging therapies, such as cancer immunotherapies, showing
promising but heterogeneous responses that are poorly understood. This study focuses on understanding how
aging-associated changes in the tumor microenvironment contribute to the immune evasive behavior of oral
cancer, with the goal of improving clinical outcomes for patients.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
604483045
UEI
FBYMGMHW4X95
Project Start Date
06-June-2024
Project End Date
31-March-2029
Budget Start Date
06-June-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$653,172
Direct Costs
$395,862
Indirect Costs
$257,310
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Dental and Craniofacial Research
$653,172
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01DE033519-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01DE033519-01
Patents
No Patents information available for 1R01DE033519-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01DE033519-01
Clinical Studies
No Clinical Studies information available for 1R01DE033519-01
News and More
Related News Releases
No news release information available for 1R01DE033519-01
History
No Historical information available for 1R01DE033519-01
Similar Projects
No Similar Projects information available for 1R01DE033519-01